MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.118
-0.007 (-5.60%)
Dec 20, 2024, 4:00 PM EST

MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of 45.05 million. The enterprise value is 141.96 million.

Market Cap 45.05M
Enterprise Value 141.96M

Important Dates

The next estimated earnings date is Monday, March 3, 2025.

Earnings Date Mar 3, 2025
Ex-Dividend Date n/a

Share Statistics

MariMed has 381.31 million shares outstanding. The number of shares has increased by 6.67% in one year.

Current Share Class n/a
Shares Outstanding 381.31M
Shares Change (YoY) +6.67%
Shares Change (QoQ) +0.29%
Owned by Insiders (%) 10.29%
Owned by Institutions (%) 0.30%
Float 342.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.28
PB Ratio 0.65
P/TBV Ratio 1.32
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.09, with an EV/FCF ratio of -24.26.

EV / Earnings -10.05
EV / Sales 0.90
EV / EBITDA 7.09
EV / EBIT 18.73
EV / FCF -24.26

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.03.

Current Ratio 1.27
Quick Ratio 0.40
Debt / Equity 1.03
Debt / EBITDA 4.47
Debt / FCF -15.29
Interest Coverage 1.15

Financial Efficiency

Return on equity (ROE) is -15.15% and return on invested capital (ROIC) is 2.79%.

Return on Equity (ROE) -15.15%
Return on Assets (ROA) 2.35%
Return on Capital (ROIC) 2.79%
Revenue Per Employee 231,468
Profits Per Employee -20,717
Employee Count 721
Asset Turnover 0.78
Inventory Turnover 3.05

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -58.01% in the last 52 weeks. The beta is 2.80, so MariMed's price volatility has been higher than the market average.

Beta (5Y) 2.80
52-Week Price Change -58.01%
50-Day Moving Average 0.15
200-Day Moving Average 0.20
Relative Strength Index (RSI) 36.16
Average Volume (20 Days) 577,375

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.01

Income Statement

In the last 12 months, MariMed had revenue of 157.86 million and -14.13 million in losses. Loss per share was -0.04.

Revenue 157.86M
Gross Profit 67.48M
Operating Income 7.58M
Pretax Income -10.35M
Net Income -14.13M
EBITDA 17.95M
EBIT 7.58M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 9.79 million in cash and 89.44 million in debt, giving a net cash position of -79.65 million or -0.21 per share.

Cash & Cash Equivalents 9.79M
Total Debt 89.44M
Net Cash -79.65M
Net Cash Per Share -0.21
Equity (Book Value) 86.84M
Book Value Per Share 0.18
Working Capital 12.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.43 million and capital expenditures -16.28 million, giving a free cash flow of -5.85 million.

Operating Cash Flow 10.43M
Capital Expenditures -16.28M
Free Cash Flow -5.85M
FCF Per Share -0.02
Full Cash Flow Statement

Margins

Gross margin is 42.74%, with operating and profit margins of 4.80% and -8.95%.

Gross Margin 42.74%
Operating Margin 4.80%
Pretax Margin -6.55%
Profit Margin -8.95%
EBITDA Margin 11.37%
EBIT Margin 4.80%
FCF Margin n/a

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.67%
Shareholder Yield -6.67%
Earnings Yield -31.65%
FCF Yield -12.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MariMed has an Altman Z-Score of 0.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.71
Piotroski F-Score n/a